Fatma Naz Cemre Kalayci, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chlamydophila Infections | 1 | 2017 | 22 | 0.570 |
Why?
|
| Neurotrophin 3 | 1 | 2017 | 61 | 0.570 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2017 | 52 | 0.570 |
Why?
|
| Helicobacter pylori | 5 | 2019 | 376 | 0.520 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2017 | 597 | 0.430 |
Why?
|
| Helicobacter Infections | 3 | 2019 | 385 | 0.220 |
Why?
|
| Clarithromycin | 2 | 2019 | 85 | 0.190 |
Why?
|
| Dyspepsia | 3 | 2019 | 116 | 0.180 |
Why?
|
| Turkey | 5 | 2019 | 249 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3801 | 0.150 |
Why?
|
| Schizophrenia | 1 | 2017 | 6910 | 0.150 |
Why?
|
| Nitrate Reductase | 1 | 2016 | 11 | 0.130 |
Why?
|
| HL-60 Cells | 1 | 2015 | 363 | 0.120 |
Why?
|
| Isoniazid | 1 | 2016 | 283 | 0.110 |
Why?
|
| Bacteriological Techniques | 1 | 2015 | 279 | 0.110 |
Why?
|
| Rifampin | 1 | 2016 | 339 | 0.110 |
Why?
|
| Point Mutation | 1 | 2019 | 1593 | 0.110 |
Why?
|
| Antigens, Bacterial | 2 | 2015 | 1155 | 0.110 |
Why?
|
| Amino Acid Motifs | 1 | 2015 | 929 | 0.100 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2019 | 1055 | 0.100 |
Why?
|
| Nasopharynx | 1 | 2014 | 394 | 0.090 |
Why?
|
| Stomach | 1 | 2015 | 694 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 7403 | 0.080 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2016 | 930 | 0.070 |
Why?
|
| Antitubercular Agents | 1 | 2016 | 1373 | 0.070 |
Why?
|
| Psychometrics | 1 | 2017 | 3052 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4567 | 0.070 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2019 | 1945 | 0.070 |
Why?
|
| Monocytes | 1 | 2015 | 2570 | 0.060 |
Why?
|
| Stomach Neoplasms | 1 | 2015 | 1422 | 0.060 |
Why?
|
| Bacterial Proteins | 2 | 2015 | 3824 | 0.060 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2016 | 1903 | 0.060 |
Why?
|
| Pneumonia | 1 | 2014 | 2129 | 0.050 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2016 | 586 | 0.050 |
Why?
|
| Genotype | 1 | 2015 | 12945 | 0.040 |
Why?
|
| Cytokines | 1 | 2015 | 7338 | 0.040 |
Why?
|
| Bipolar Disorder | 1 | 2017 | 5079 | 0.040 |
Why?
|
| RNA, Ribosomal, 23S | 1 | 2019 | 54 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2015 | 3425 | 0.040 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2019 | 763 | 0.040 |
Why?
|
| Translations | 1 | 2017 | 81 | 0.030 |
Why?
|
| Nitrites | 1 | 2016 | 159 | 0.030 |
Why?
|
| Colorimetry | 1 | 2016 | 148 | 0.030 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2015 | 93 | 0.030 |
Why?
|
| Adhesins, Bacterial | 1 | 2015 | 118 | 0.030 |
Why?
|
| Tetracycline | 1 | 2015 | 219 | 0.030 |
Why?
|
| Nitrates | 1 | 2016 | 263 | 0.030 |
Why?
|
| Amoxicillin | 1 | 2015 | 180 | 0.030 |
Why?
|
| Breath Tests | 1 | 2015 | 297 | 0.030 |
Why?
|
| Metronidazole | 1 | 2015 | 231 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2017 | 22029 | 0.030 |
Why?
|
| Geography | 1 | 2015 | 660 | 0.030 |
Why?
|
| Young Adult | 5 | 2019 | 58808 | 0.030 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2014 | 238 | 0.030 |
Why?
|
| Virulence Factors | 1 | 2015 | 511 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2015 | 1456 | 0.020 |
Why?
|
| Viruses | 1 | 2014 | 376 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 15225 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 20055 | 0.020 |
Why?
|
| Humans | 9 | 2019 | 758406 | 0.020 |
Why?
|
| Adult | 6 | 2019 | 219935 | 0.020 |
Why?
|
| Aged | 5 | 2019 | 168218 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 6068 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3774 | 0.020 |
Why?
|
| Middle Aged | 5 | 2019 | 219568 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 4711 | 0.010 |
Why?
|
| Biopsy | 1 | 2015 | 6768 | 0.010 |
Why?
|
| Adolescent | 3 | 2017 | 87892 | 0.010 |
Why?
|
| Bacteria | 1 | 2014 | 2197 | 0.010 |
Why?
|
| Male | 5 | 2019 | 358747 | 0.010 |
Why?
|
| Phenotype | 1 | 2019 | 16534 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 14641 | 0.010 |
Why?
|
| Female | 5 | 2019 | 390323 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2015 | 23884 | 0.010 |
Why?
|
| Infant | 1 | 2014 | 36055 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 42062 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2015 | 54137 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 58683 | 0.010 |
Why?
|
| Child | 1 | 2014 | 79818 | 0.000 |
Why?
|